Inventor

WISCHIK CLAUDE MICHEL

GB52 patents

⚠️ This page may combine multiple inventors who share the name “WISCHIK CLAUDE MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WISCHIK CLAUDE MICHEL

WISTA LAB LTD

Methods of synthesis and/or purification of diaminophenothiazinium compounds

3, 7-diamino-10H-phenothiazine salts and their use

Administration and dosage of diaminophenothiazines

Administration and dosage of diaminophenothiazines

Administration and dosage of diaminophenothiazines

Methods of synthesis and/or purification of diaminophenothiazinium compounds

Methods of synthesis and/or purification of diaminophenothiazinium compounds

Therapeutic use of diaminophenothiazines

Methods of synthesis and/or purification of diaminophenothiazinium compounds

Methods of synthesis and/or purification of diaminophenothiazinium compounds

Methods of synthesis and/or purification of diaminophenothiazinium compounds

3,7-diamino-10H-phenothiazine salts and their use

Neurofibrillary labels

Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer&#39;s and related neurodegenerative disorders

Medical methods utilising high purity diaminophenothiazinium compounds

Medical methods utilising high purity diaminophenothiazinium compounds

High purity diaminophenothiazinium compounds including methylthioninium chloride (MTC)

Phenothiazine diaminium salts and their use

Phenothiazine diaminium salts and their use

Treatment of dementia

Materials and methods relating to protein aggregation in neurodegenerative disease

Materials and methods relating to protein aggregation in neurodegenerative disease

Neurofibrillary labels

3, 7-diamino-10H-phenothiazine salts and their use

Methods of synthesis and/or purification of diaminophenothiazinium compounds

Medical methods utilising high purity diaminophenothiazinium compounds

Phenothiazine diaminium salts and their use

Inhibition of tau-tau association

Optimised dosage of diaminophenothiazines in populations

Optimised dosage of diaminophenothiazines in populations

3,7-diamino-10H-phenothiazine salts and their use

3, 7-diamino-10H-phenothiazine salts and their use

Administration and dosage of diaminophenothiazines

Phenothiazine diaminium salts and their use

3,6-disubstituted xanthylium salts

3,6-disubstituted xanthylium salts

Materials and methods relating to protein aggregation in neurodegenerative disease

WISCHIK CLAUDE MICHEL

Inhibitors of protein aggregation

Therapeutic use of diaminophenothiazines

3,7-diamino-10H-phenothiazine salts and their use

Phenothiazine compounds for treating mild cognitive impairment

Inhibition of tau-tau-association

Methods of synthesis and/or purification of diaminophenothiazinium compounds

Neurofibrillary labels

CLUNAS SCOTT

Phenothiazine diaminium salts and their use

3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies

UNIV ABERDEEN

Inhibition of tau-tau association

Screening methods for agents that modulate or inhibit tau association with tau or map2

STOREY JOHN MERVYN DAVID

High purity diaminophenothiazinium compounds including methylthioninium chloride (MTC)

GENTING TAURX DIAGNOSTIC CENTRE SDN BHD

Method and system for determining network connections

Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders